Charles Schwab Investment Management Inc. boosted its stake in shares of Quantum-Si incorporated (NASDAQ:QSI – Free Report) by 32.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 308,021 shares of the company’s stock after buying an additional 75,661 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Quantum-Si were worth $832,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of QSI. Bravias Capital Group LLC bought a new stake in Quantum-Si in the 4th quarter valued at approximately $55,000. SBI Securities Co. Ltd. bought a new position in shares of Quantum-Si during the 4th quarter worth approximately $60,000. Bank of New York Mellon Corp raised its holdings in shares of Quantum-Si by 21.3% in the fourth quarter. Bank of New York Mellon Corp now owns 269,807 shares of the company’s stock valued at $728,000 after purchasing an additional 47,400 shares during the last quarter. Wolverine Asset Management LLC bought a new stake in shares of Quantum-Si in the fourth quarter worth $26,000. Finally, Sanctuary Advisors LLC acquired a new position in Quantum-Si during the fourth quarter worth $95,000. Institutional investors own 39.90% of the company’s stock.
Quantum-Si Trading Down 3.1 %
NASDAQ QSI opened at $1.27 on Monday. The firm has a market capitalization of $232.59 million, a P/E ratio of -1.98 and a beta of 2.75. The firm’s fifty day moving average price is $1.71 and its two-hundred day moving average price is $1.50. Quantum-Si incorporated has a 1 year low of $0.61 and a 1 year high of $5.77.
Insider Transactions at Quantum-Si
Analyst Ratings Changes
Several equities research analysts have commented on QSI shares. HC Wainwright reissued a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a research report on Tuesday, January 14th. National Bankshares set a $3.65 target price on Quantum-Si in a research report on Wednesday, March 5th. Finally, Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a research report on Wednesday, March 5th.
Read Our Latest Report on Quantum-Si
Quantum-Si Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Articles
- Five stocks we like better than Quantum-Si
- How to buy stock: A step-by-step guide for beginners
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- The 3 Best Fintech Stocks to Buy Now
- MarketBeat Week in Review – 03/24 – 03/28
- Upcoming IPO Stock Lockup Period, Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding QSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quantum-Si incorporated (NASDAQ:QSI – Free Report).
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.